Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Episode 69: Prof. Tim Henrich - Viral persistence and T cell dysregulation

Episode 69: Prof. Tim Henrich - Viral persistence and T cell dysregulation

FromTLC Sessions - Living with Long Covid


Episode 69: Prof. Tim Henrich - Viral persistence and T cell dysregulation

FromTLC Sessions - Living with Long Covid

ratings:
Length:
68 minutes
Released:
Jan 23, 2024
Format:
Podcast episode

Description

Tim Henrich is a Professor of Medicine and expert in infectious diseases, focused on chronic viral infections at the University of California, San Francisco. He is another member of the titan Long Covid research team who have tracked patients since the beginning of the pandemic (LIINC study) and are making roads into understanding the mechanism of the disease and potentials for treating it.In this week’s episode he talks us through some of the exciting work that he is doing, alongside our previous guests Steven Deeks & Michael Peluso.  Using a combination of longitudinal studies, biopsies and high resolution PET / CT imaging, the team have established changes to t cells throughout the bodies of Long Covid patients, and found evidence of viral persistence.  They are currently conducting multiple clinical trials including monoclonal antibodies to act on viral reservoirs, and the anti-viral Ensitrelvir which has undergone several trials in active SARS-COV2 previously, and believe that they are getting to grips with the pathophysiology of the disease.Living with Long Covid? How was your week?Website - https://www.tlcsessions.net/Twitter - @SessionsTlc https://twitter.com/sessionstlcInsta - @tlcsessions https://www.instagram.com/tlcsessions
Released:
Jan 23, 2024
Format:
Podcast episode

Titles in the series (79)

A podcast dedicated to Long Covid. Noreen Jameel and Emily Kate Stephens talk to fellow sufferers, doctors and experts searching for answers about this new, debilitating post-viral condition. So if you are one of the millions suffering from, or interested in, this new condition - tune in to our weekly podcast.